Clonazepam
- Product NDC
- 70518-2392
- 11-digit product format
- 705182392
- Labeler code
- 70518
- Product ID
- 70518-2392_c8bdb38e-1d94-b42b-e053-2a95a90af9aa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clonazepam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA077856
- Marketing category
- ANDA
- Marketing start
- 2019-10-26
- Marketing end
- 0000-00-00
- Substance
- CLONAZEPAM
- Active strength
- 1 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 70518-2392-0 | 2023-03-09 | C162847 | 48780-1 | f386c649-e36b-0266-e053-dadaa90a7c1a | CLONAZEPAM TABLETS, USP 0.5 mg, 1 mg and 2 mg CIV Rx only |
| 70518-2392-0 | 2023-03-09 | C162847 | 48780-1 | f386c649-e36b-0266-e053-dadaa90a7c1a | CLONAZEPAM TABLETS, USP 0.5 mg, 1 mg and 2 mg Rx only |
| 70518-2392-0 | 2023-01-30 | C162847 | 48780-1 | f386c649-e36b-0266-e053-dadaa90a7c1a | CLONAZEPAM TABLETS, USP 0.5 mg, 1 mg and 2 mg CIV Rx only |
| 70518-2392-0 | 2023-01-30 | C162847 | 48780-1 | f386c649-e36b-0266-e053-dadaa90a7c1a | CLONAZEPAM TABLETS, USP 0.5 mg, 1 mg and 2 mg Rx only |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-2392 | CLONAZEPAM TABLET [REMEDYREPACK INC.] | 7 | Legacy NDC | 20250316_6a051f02-5826-4f9e-bb9c-5b5520796803.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2392-0 | 70518239200 | 100 POUCH in 1 BOX, UNIT-DOSE (70518-2392-0) > 1 TABLET in 1 POUCH (70518-2392-1) | 100 pouch | 2019-10-26 | 0000-00-00 | No | No | Current |